Company Information
USD
2.11
- (-13.2%)
NASDAQ:BCAB, BIOATLA, INC.
Industry: Biotechnology
End of Day: 19 April 2024 GMT-4
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs.
Address
11085 Torreyana Road
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Richard A. Waldron
CFO/Senior VP
Mr. Christian Vasquez
Chief Accounting Officer/Controller/Secretary
Mr. Scott A. Smith
Director
Dr. Lawrence J. Steinman, M.D.
Director
Dr. Mary Ann Gray,PhD
Director
Dr. Jay M. Short,PhD
CEO/Chairman of the Board/Co-Founder/Director
Ms. Sylvia McBrinn
Director
Dr. Eric Sievers, M.D.
Chief Medical Officer
Mr. Edward Williams
Director
Dr. Susan Moran, M.D.
Director
Ownership
Institution Holdings
Soleus Capital Management, L.P.
4,065,197 (8.481%)
TANG CAPITAL MANAGEMENT LLC
3,778,393 (7.882%)
Tang Capital Partners LP
3,124,076 (6.517%)
BlackRock Inc
2,884,014 (6.016%)
Vanguard Group Inc
2,081,370 (4.342%)
Morgan Stanley - Brokerage Accounts
1,913,115 (3.991%)
BlackRock Fund Advisors
1,557,426 (3.249%)
Vanguard Investments Australia Ltd
1,267,868 (2.645%)
Cormorant Asset Management, LLC
1,181,115 (2.464%)
Deutsche Bank AG
1,125,203 (2.347%)
Individual Holdings
Dr. Jay M. Short,PhD
1,856,283 (3.872%)
Mr. Scott A. Smith
294,636 (0.615%)
Mr. Richard A. Waldron
230,923 (0.482%)
Dr. Eric Sievers, M.D.
210,994 (0.440%)
Mr. Christian Vasquez
185,659 (0.387%)
Dr. Lawrence J. Steinman, M.D.
38,459 (0.080%)
Dr. Mary Ann Gray,PhD
37,397 (0.078%)
Mr. Edward Williams
20,200 (0.042%)
Dr. Susan Moran, M.D.
12,307 (0.042%)
Ms. Sylvia McBrinn
19,125 (0.040%)
Funds Holdings
iShares Russell 2000 ETF
1,046,188 (2.182%)
DWS Small Cap Core Fund
670,000 (1.398%)
iShares Russell 2000 Value ETF
411,168 (0.858%)
Vanguard Russell 2000 Index Fund
146,160 (0.305%)
NT R2000 Index Fund - NL
119,982 (0.250%)
Bridgeway Ultra Small Company Market Fd
112,000 (0.234%)
BlackRock - Extended Mkt Fund CF
98,805 (0.206%)
NT R2000 Index Fund - DC - NL
94,487 (0.197%)
BlackRock Extended Equity Market
85,060 (0.177%)
Russell 2000 Index Non-Lendable Fund E
81,211 (0.169%)
Make Smart Investment Choices